Clinical Experiences with Isoxsuprine

Abstract

Get full access to this article

View all access options for this article.

References

New and Nonofficial Drugs 1959, p. 217. J. B. Lippincott Co., Philadelphia, 1959.

Brucke, F. , Hertting, G. , Lindner, A. , AND Loudon, M. : The pharmacology of a new vasodilating substance of the p-hydroxyephedrine series. Wien. Klin. Wchnschr., 68: 183, 1956.

Kaindl, F. , Partan, J. , AND Polsterer, P. : Clinical use of a new vasodilator. Wien. Klin. Wchnschr. , 68: 186, 1956.

Weghaupt, K. : Results of treatment with a new vasodilator in patients with severe disturbances of blood supply in the lower extremities . Wien. Klin. Wchnschr., 69: 31,1957.

Singer, R. : Conservative management of the peripheral circulation. Wien. med. Wchnschr., 107: 734, 1957.

Kraucher, C. : Experiences with a new vasodilator in disturbances of blood flow. Prakt. Arzt., 11: 325, 1957.

Kaindl, F. , Samuels, S.S. , Selman, D. , AND Shaftel, H.E. : A new vasodilator and antispasmodic agent: isoxsuprine hydrochloride . Angiology, 10: 185, 1959.

Samuels, S.S. , AND Shaftel, H.E. : Use of a new vasodilator agent in management of peripheral anterial insufficiency. J. A. M. A., 171: 142, 1959.

Weikel, J.H. , JR., Wheeler, A.C. , AND Joiner, P.D. : Toxicology, absorption and physiological disposition of isoxsuprine (Vasodilan). Toxicol. and App. Pharmacol., 1: 579, 1959.